Acetaminophen-induced acute liver failure treated with single-pass albumin dialysis: Report of a case

International Journal of Artificial Organs

Volumn 31, Issue 5, 2008, Pages 450-455

  Karvellas, C J ^a   Bagshaw, Sean M ^a   McDermid, R C ^a   Stollery, D E ^a   Gibney, R T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acetaminophen; Acute liver failure; Critically til; Extracorporeal; Fulminant hepatic failure; Multi organ failure; Single pass albumin dialysis

Indexed keywords

ARTIFICIAL ORGANS; DIAGNOSIS; PATIENT REHABILITATION; PATIENT TREATMENT; RECOVERY;

ACETAMINOPHEN; ACUTE LIVER FAILURE; CRITICALLY TIL; EXTRACORPOREAL; FULMINANT HEPATIC FAILURES; LIVER TRANSPLANTATION; MULTI-ORGAN FAILURE; ORGAN FAILURE; SINGLE PASS; SINGLE-PASS ALBUMIN DIALYSIS;

DIALYSIS;

ACETYLCYSTEINE; MANNITOL; PARACETAMOL; PHENYTOIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BRAIN EDEMA; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; CONVALESCENCE; DISEASE COURSE; DRUG OVERDOSE; FEMALE; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; KIDNEY FUNCTION; LACTIC ACIDOSIS; LIVER FAILURE; LIVER FUNCTION; PSYCHOSOCIAL DISORDER; SINGLE DRUG DOSE; SINGLE PASS ALBUMIN DIALYSIS;

EID: 47249095345     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100511     Document Type: Article

References (31)

1. Fagan E, Wannan G. Reducing paracetamol overdoses. BMJ 1996; 313:1417-8.
2. Bernal W. Intensive care support therapy. Liver Transpl 2003; 9: S15-7.
3. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-72.
4. Myers RP, Li B, Fong A, Shaheen AA, Quan H. Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health 2007; 7: 143.
5. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
6. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-98.
7. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35: 2498-2505.
8. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 2002; 22 (Suppl 2): S5-13.
9. Corbally M, Rela M, Heaton N, Tan K. Standard orthotopic operation, retransplantation and piggybacking. In: Williams R, Portmann B, Tan K, eds. The Practice of Liver Transplantation. Edinburgh: Churchill Livingstone; 1995. p 135-42.
10. Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol 2005; 100: 468-75.
11. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-86.
12. Rifai K, Ernst T, Kretschmer U, et al. Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 2003; 39: 984-90.
13. Karvellas CJ, Gibney N, Kutsogiannis D, Wendon J, Bain VG. Bench to Bedside: Current evidence for extracorporeal albumin dialysis systems in liver failure. Crit Care 2007; 11: 215.
14. Evans TW. Review article: albumin as a drug - biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 2002; 16 (Suppl 5): S6-11.
15. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31: 1080-5.
16. Sauer IM, Goetz M, Steffen I, et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39: 1408-14.
17. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 ; 33: 464-70.
18. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology. 2002; 36 (4 Pt 1): 949-58.
19. Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003; 9: 290-7.
20. Skwarek A, Grodzicki M, Nyckowski P, et al. The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc 2006; 38: 209-11.
21. Chawla LS, Georgescu F, Abell B, Seneff MG, Kimmel PL. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 2005; 45: e51-6.
22. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27: 1050-5.
23. Brandsaeter B, Hockerstedt K, Friman S, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transpl 2002; 8: 1055-62.
24. Camus C, Lavoue S, Gacouin A, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006; 32: 1817-25.
25. Isoniemi H, Koivusalo AM, Repo H, Ilonen I, Hockerstedt K. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transplant Proc 2005; 37: 1088-90.
26. Doria C, Mandala L, Smith JD, et al. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004; 18: 365-71.
27. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: A worldwide practice survey. The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med 2007; 33: 1563-70.
28. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous venovenous hemofiltration without anticoagulation. ASAIO J 2004; 50: 76-80.
29. Okamoto K, Kurose M, Ikuta Y, et al. Prolonged artificial liver support in a child with fulminant hepatic failure. ASAIO J 1996; 42: 233-5.
30. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Int J Artif Organs 1996; 20: 1169-72.
31. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med 2001; 134: 330-4.